The Technology Co.,Ltd.

Equities

A043090

KR7043090000

Industrial Machinery & Equipment

End-of-day quote Korea S.E. Other stock markets 06:00:00 2024-04-23 pm EDT			5-day change	1st Jan Change
450 ^KRW	+0.90%		-3.02%	-29.69%

Mar. 22	PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	CI
Mar. 21	PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	CI

PharmswellBio Co., Ltd. announced that it has received KRW 10.099999693 billion in funding from Ariel Partners Limited

June 11, 2019

On June 12, 2019, PharmswellBio Co., Ltd. (KOSDAQ:A043090 closed the transaction. The company announced that it has issued bonds for the gross proceeds of KRW 5,100,000,000 in its second tranche, brining the total funding to KRW 10,099,999,693.

Latest news about The Technology Co.,Ltd.

PangSky Corp. announced that it has received KRW 1 billion in funding from Exergy21 Co., Ltd.	Mar. 21	CI
PangSky Corp. announced that it expects to receive KRW 1 billion in funding from Exergy21 Co., Ltd.	Mar. 20	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 24.999999475 billion in funding	23-08-17	CI
Kattus Co., Ltd. announced that it has received KRW 5.999 billion in funding from Exergy21 Co., Ltd.	23-05-02	CI
Kattus Co., Ltd. announced that it expects to receive KRW 5.999 billion in funding from Exergy21 Co., Ltd.	23-04-25	CI
Exergy21 Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-21	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 25 billion in funding	23-03-15	CI
Hanchang Biotech Co., Ltd. announced that it has received KRW 15 billion in funding from Exergy21.Inc	22-10-16	CI
HanChang Biotech to Raise $9.2 Million Through Stock Offering	22-08-04	MT
Hanchang Corporation entered into an agreement to acquire 73.98% for KRW 25 billion.	22-08-04	CI
Exergy21 Co., Ltd. announced that it expects to receive KRW 79.99999938 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.5 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 15 billion in funding from Exergy21.Inc	22-08-03	CI
An undisclosed buyer agreed to acquire 8.6% stake in Hanchang Biotech Co., Ltd. from Hanchang Corporation for KRW 6.8 billion.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 27.49999938 billion in funding	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 11.99999925 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. announced that it expects to receive KRW 12.49999938 billion in funding from Jeonheung CNC Co., Ltd.	22-08-03	CI
Hanchang Biotech Co., Ltd. acquired 5.61% stake in Hanju Chemical Company Ltd for KRW 2.7 billion.	21-12-26	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 12.49999978 billion in funding from Hanchang Corporation, Jaanh Holdings Co., Ltd., CHOROKBAEM COMPANY Co., Ltd.	21-10-28	CI
Hanju Chemical & Holdings Co., Ltd. announced that it has received KRW 8 billion in funding from Jiyuon Co., Ltd.	21-10-20	CI
Hanju Chemical & Holdings Co., Ltd. announced that it expects to receive KRW 8 billion in funding from Jiyuon Co., Ltd.	21-10-18	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 17.49999934 billion in funding from Jaanh Cosmetics, Inc.	21-06-15	CI
Cube&Company Co., Ltd. announced that it expects to receive KRW 12.49999978 billion in funding from CHOROKBAEM COMPANY Co., Ltd.	21-03-28	CI
PharmswellBio Co., Ltd. announced that it has received KRW 4.999997086 billion in funding from Cube Partners, C.S. Global Co., Ltd.	19-09-23	CI
PharmswellBio Co., Ltd.(KOSDAQ:A043090) dropped from S&P Global BMI Index	19-09-23	CI

Chart The Technology Co.,Ltd.

Duration

Period

More charts

Company Profile

The Technology Co Ltd, formerly Exergy21 Co Ltd, is a Korea-based company mainly engaged in the distribution business. The Company manly operates its business through four segments. The Distribution Business segment engages in the food processors, luxury goods, healthy food, kitchen appliances and home shopping goods distribution business. The PM business segment provides consulting services for real estate development, licensing, and contractor selection. The Pharmaceutical segment engages in ethanol and disinfectant manufacture business. The Other segment provides business support services. The Company also engages in information technology (IT) services, artificial intelligence (AI) and drone based security solutions, as well as heat pump system provision business.

Sector

Industrial Machinery & Equipment

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Industrial Machinery & Equipment Wholesale

	1st Jan change	Capi.
THE TECHNOLOGY CO.,LTD.	-29.69%	22.94M
W.W. GRAINGER, INC.	+15.64%	47B
FASTENAL COMPANY	+4.59%	38.65B
APPLIED INDUSTRIAL TECHNOLOGIES, INC.	+7.76%	7.2B
MSC INDUSTRIAL DIRECT CO., INC.	-7.74%	5.25B
DNOW INC.	+30.48%	1.65B
DISTRIBUTION SOLUTIONS GROUP, INC.	+6.81%	1.6B
BUFAB AB	-0.26%	1.35B
TRUSCO NAKAYAMA CORPORATION	+2.29%	1.04B
MRC GLOBAL INC.	+5.99%	1.03B

Industrial Machinery & Equipment Wholesale